Editorial: T cell specificity and cross-reactivity - implications in physiology and pathology.
| Autor: | Latorre D; Institute of Microbiology, ETH Zurich, Zurich, Switzerland., Monticelli S; Institute for Research in Biomedicine, Università della Svizzera italiana (USI), Bellinzona, Switzerland., Wypych TP; Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland., Aschenbrenner D; Immunology Disease Area, Novartis BioMedical Research, Basel, Switzerland., Notarbartolo S; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in immunology [Front Immunol] 2024 Feb 28; Vol. 15, pp. 1385415. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024). |
| DOI: | 10.3389/fimmu.2024.1385415 |
| Abstrakt: | Competing Interests: Author DA is employed by Novartis Pharma AG and a shareholder of Novartis Pharma AG. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|